Adjuvia Therapeutics is a clinical-stage biopharmaceutical company.
Adjuvia Therapeutics has raised $8.0M in total funding. The most recent round was Seed. The last funding was announced in July 2026.
Adjuvia Therapeutics's investors include Portfolia, JLo Ventures.
Adjuvia Therapeutics is headquartered in San Francisco, United States.
Adjuvia Therapeutics is a clinical-stage biopharmaceutical company.
Adjuvia Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Adjuvia Therapeutics — Funding & Investors." VCBacked, July 29, 2026, https://www.vcbacked.co/company/adjuvia-therapeutics. Accessed August 1, 2026.
VCBacked. (2026). Adjuvia Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/adjuvia-therapeutics
{{cite web |title=Adjuvia Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/adjuvia-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated